Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01982383 · ClinicalTrials.gov registry record · NA
Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy
A NA study, sponsored by George Washington University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01982383 is a NA study that was terminated before completion, run by George Washington University. The registered enrollment target is 2 participants.
The verdict
NCT01982383, a NA study, was terminated before completion, sponsored by George Washington University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The investigators hypothesis is that using the micropulse laser in patient with Central Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in significantly minimizing visual recovery time from this disease as well as potentially preventing recurrences.
Interventions
- OTHER No treatment
- DEVICE Micropulse Laser Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01982383
The ClinicalTrials.gov registry entry for NCT01982383 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which No treatment is the first listed.
NCT01982383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01982383 about?
NCT01982383 is a clinical study titled "Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy". The investigators hypothesis is that using the micropulse laser in patient with Central Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in significantly minimizing visual recovery time from this disease as well as potentially preventing recurrences.
What is the current status of trial NCT01982383?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2012-11. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01982383?
The interventions under investigation include: No treatment (OTHER), Micropulse Laser Treatment (DEVICE).
Who is sponsoring clinical trial NCT01982383?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.